On Monday, Absci Corp (ABSI) stock saw a decline, ending the day at $3.81 which represents a decrease of $-0.19 or -4.75% from the prior close of $4. The stock opened at $3.88 and touched a low of ...

Ballentine Partners LLC bought a new stake in Absci Co. (NASDAQ:ABSI – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm bought 10,424 shares of the company’s stock, valued at ...

Absci Corp (ABSI) stock saw a decline, ending the day at $4 which represents a decrease of $-0.17 or -4.08% from the prior close of $4.17. The stock opened at $4.16 and touched a low of $3.92 during ...

The Stargate Project, a $500B initiative focused on artificial intelligence, lifts AI-driven biotech stocks and an unlikely ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Equities research analysts at Needham & Company LLC assumed coverage on shares of Absci (NASDAQ:ABSI – Get Free Report) in a ...

According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a ...

"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...

Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...

Real-time index price for Nasdaq Other Finance Index (OFIN), along with buy or sell indicators, analysis, charts, historical ...

Absci Corp. (NASDAQ:ABSI) shares, currently trading at $3.22, received a positive outlook from Needham as the firm began coverage with a Buy rating and set a price target of $9.00. The stock has shown ...

Absci management is scheduled to participate in a fireside chat on Wednesday, February 5 th at 3:00 p.m. Eastern Time (12:00 p.m. Pacific Time). Interested parties may access a live and archived ...